Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Lublin

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Neurology|January 24, 2002
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]D S Goodin, E M Frohman, G P Garmany, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsJ W Lindsey, T F Scott, S G Lynch, et al.
Neurology|September 30, 2009
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialW King Engel, F Fazekas, F D Lublin, et al.
Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2010
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeksS A Morrow, P W O'Connor, C H Polman, et al.
Neurology|November 15, 2006
Infusion-related hypersensitivity reactions during natalizumab treatmentJ T Phillips, P W O'Connor, E Havrdova, et al.
Neurology|June 10, 2009
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1aR A Rudick, A Pace, M R S Rani, et al.
Neurology|February 1, 1997
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosisA E Miller, L A Morgante, L Y Buchwald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Assessing disability progression with the Multiple Sclerosis Functional CompositeR A Rudick, C H Polman, J A Cohen, et al.
Annals of Neurology|July 18, 2001
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosisW I McDonald, A Compston, G Edan, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Neurology|January 24, 2002
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]D S Goodin, E M Frohman, G P Garmany, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsJ W Lindsey, T F Scott, S G Lynch, et al.
Neurology|September 30, 2009
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialW King Engel, F Fazekas, F D Lublin, et al.
Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2010
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeksS A Morrow, P W O'Connor, C H Polman, et al.
Neurology|November 15, 2006
Infusion-related hypersensitivity reactions during natalizumab treatmentJ T Phillips, P W O'Connor, E Havrdova, et al.
Neurology|June 10, 2009
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1aR A Rudick, A Pace, M R S Rani, et al.
Neurology|February 1, 1997
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosisA E Miller, L A Morgante, L Y Buchwald, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Assessing disability progression with the Multiple Sclerosis Functional CompositeR A Rudick, C H Polman, J A Cohen, et al.
Annals of Neurology|July 18, 2001
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosisW I McDonald, A Compston, G Edan, et al.
Pageof 10